Emanuele Monda
@MondaEmanuele
Followers
9K
Following
3K
Statuses
2K
MD | FESC | Cardiologist | Media Task Force Member #ESC Council CV Genomics | Cardiomyopathies and Inherited CV Diseases
Naples, Campania
Joined June 2019
RT @SilCastelletti: 📚#EJPC Paper Elite #athletes #aortic dimension: updated systematic review and meta-analysis by @MondaEmanuele @glimonge…
0
6
0
RT @ehj_ed: Exercise training, especially in-person sessions, was associated with improved health-related quality of life:, depression and…
0
35
0
RT @SilCastelletti: #ESCPrev2025 Late-Breaking Science call: Present your latest research in #preventive #cardiology! Deadline January 21st…
0
15
0
RT @NEJMEvidence: In this statistical editorial, Larry Han, PhD, reviews the concept of left truncation in time-to-event studies. Read the…
0
9
0
RT @ehj_ed: Can a glass of wine leave its mark on your health? Dive into 'Urinary tartaric acid as a biomarker of wine consumption and car…
0
15
0
RT @HanCardiomd: Editorial by #EugeneBraunwald : Advances in the treatment of #HCM Timeline for hypertrophic cardiomyopathy (HCM) treatme…
0
91
0
RT @HanCardiomd: The hypothesis: a new article type and platform for #iconoclasts in medicine By #MiltonPacker #…
0
8
0
RT @JACCJournals: In sarcomeric #HCM patients, coexistence of non-HCM related genetic variants increases the risk of the progression to end…
0
28
0
RT @ACCinTouch: Top 🔟 Clinical Trials of 2024: 🔥 PREVENT 🔥 DanGer Shock 🔥 REDUCE-AMI 🔥 CLEAR SYNERGY (OASIS 9) 🔥 And more! Read the detai…
0
69
0
RT @PanichellaG: Feeling incredibly honored and grateful to see this work featured in @JACCJournals alongside such renowned experts! 🌟 Thi…
0
9
0
RT @ESC_Journals: Prevalence of transthyretin cardiac amyloidosis in undifferentiated heart failure with preserved ejection fraction 👉 http…
0
42
0
RT @Ed_Alania: 🧬Integration of genetic testing into diagnostic pathways for cardiomyopathies: 📕A clinical consensus statement by the ESC…
0
26
0
RT @Ed_Alania: 🔴 2024 ACC Expert Consensus Decision Pathway on Strategies & Criteria for the Diagnosis & Management of Myocarditis @JACCJou…
0
50
0
RT @dr_pavia: Should betablockers (BB) be avoided in patients with ATTR amyloidosis? Come with me to explore our latest study. Long 🧵👇(1/15)
0
50
0
RT @Ed_Alania: 🔴 Hypertrophic cardiomyopathy evolving management 🇺🇸vs🇪🇺 @ESC_Journals #CardioEd #cardiology #cardiotwitter
0
21
0
RT @FeliceGragnano: Will #MRAs give impact on #HFpEF pharmacotherapy in addition to SGLT2-I? A new #Pharmapulse is online 📡 👉 https://t.co/…
0
3
0
RT @FeliceGragnano: PRECISE-HBR is a novel #bleeding risk score 🩸developed by augmenting the PRECISE-DAPT score with the ARC-HBR criteria 📊…
0
39
0
RT @BiykemB: 🤩Ed.Board, New Features, Paper Types at #JACCHF. Honored to have these outstanding editors lead: @akshaydesaimd @lamcardio as…
0
20
0